2,942
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Aqueous and methanol extracts of Vernonia amygdalina leaves exert their anti-obesity effects through the modulation of appetite-regulatory hormones

, , &
Pages 3232-3236 | Received 09 Feb 2016, Accepted 19 Jul 2016, Published online: 27 Aug 2016

References

  • Akarolo-Anthony SN, Willet WC, Spiegelman D, Adebamowo CA. 2014. Obesity epidemic has emerged among Nigerians. BMC Public Health. 14:455. doi:10.1186/1471-2458-14-455.
  • Barrett ML, Udani JK. 2011. A proprietary alpha-amylase inhibitor from white bean (Phaseolus vulgaris): a review of clinical studies on weight loss and glycemic control. Nutr J. 10:24. DOI: 10.1186/1475-2891-10-24.
  • Bays HE. 2004. Current and investigational antiobesity agents and obesity therapeutic treatment targets. Obes Res. 12:1197–1211.
  • Birari RB, Bhutani KK. 2007. Pancreatic lipase inhibitors from natural sources: unexplored potential. Drug Discov Today. 12:879–889.
  • Bouassida A, Chamari K, Zaouali M, Feki Y, Zbidi A, Tabka Z. 2010. Review on leptin and adiponectin responses and adaptations to acute and chronic exercise. Br J Sports Med. 44:620–630.
  • Buettner R, Scholmerich J, Bollheimer LC. 2007. High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity (Silver Spring). 15:798–808.
  • Clegg DJ, Benoit SC, Reed JA, Woods SC, Dunn-Meynell A, Levin BE. 2005. Reduced anorexic effects of insulin in obesity-prone rats fed a moderate-fat diet. Am J Physiol Regul Integr Comp Physiol. 288:R981–R986.
  • Drazen DL, Woods SC. 2003. Peripheral signals in the control of satiety and hunger. Curr Opin Clin Nutr Metab Care. 6:621–629.
  • Egedigwe CA, Ejike CECC, Ijeh II, Onwuka GI, Herbert U, Asumugha AV. 2016. Anti-obesity potentials of aqueous and methanol extracts of Vernonia amygdalina Del. leaves in high-fat diet fed rats. Afr J Trad Complement Alternat Med. 13:86–93.
  • Ejike CECC, Ikwuegbu CE, Abalogu RC. 2015. Obesity determined by different measures and its impact on the health-related quality of life of young-adult Nigerians. Asian J Clin Nutr. 7:64–75.
  • Faraj M, Havel PJ, Phelis S, Blanck D, Snideman AD, Cianflone K. 2003. Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab. 88:1594–1602.
  • French S, Castiglione K. 2002. Recent advances in the physiology of eating. Proc Nutr Soc. 61:489–496.
  • Hagemann D, Meier JJ, Gallwitz B, Schmidt WE. 2003. Appetite regulation by ghrelin—a novel neuro-endocrine gastric peptide hormone in the gut-brain-axis. Z Gastroenterol. 41:929–936.
  • Hasani-Ranjbar S, Jouyandeh Z, Abdollahi M. 2013. A systematic review of antiobesity medicinal plants - an update. J Diabetes Metab Disord. 12:28. doi:10.1186/2251-6581-12-28.
  • Ijeh II, Ejike CECC. 2011. Current perspectives on the medicinal potentials of Vernonia amygdalina Del. J Med Plants Res. 5:1051–1061.
  • Klok MD, Jakobsdottir S, Drent ML. 2006. The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review. Obes Rev. 8:21–34.
  • Klöting N, Fasshauer M, Dietrich A, Kovacs P, Schön MR, Kern M, Stumvoll M, Blüher M. 2010. Insulin-sensitive obesity. Am J Physiol Endocrinol Metab. 299:E506–E515.
  • Levin BE, Dunn-Meynell AA. 2002. Reduced central leptin sensitivity in rats with diet-induced obesity. Am J Physiol Regul Integr Comp Physiol. 283:R941–R948.
  • Levin BE, Dunn-Meynell AA, Banks WA. 2004. Obesity-prone rats have normal blood-brain barrier transport but defective central leptin signaling prior to obesity onset. Am J Physiol Regul Integr Comp Physiol. 286:R143–R150.
  • Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, Mullany EC, Biryukov S, Abbafati C, Abera SF, et al. 2014. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 384:766–781.
  • Shi Y, Burn P. 2004. Lipid metabolic enzymes: Emerging drug targets for the treatment of obesity. Nat Rev Drug Discov. 3:695–710.
  • Ueno H, Yamaguchi H, Kangawa K, Nakazato M. 2005. Ghrelin: a gastric peptide that regulates food intake and energy homeostasis. Regul Pept. 126:11–19.
  • Webber J. 2003. Energy balance in obesity. Proc Nutr Soc. 62:539–543.
  • World Health Organisation (WHO). 2012. World Health Statistics, 2012 [Internet]. Geneva: WHO. [cited 2012 Mar 3]. Available from: http://www.who.int/gho/publications/world_health_statistics/WHS2012_IndicatorCompendium.pdf.
  • Yildiz BO, Suchard MA, Wong ML, McCann SM, Licinio J. 2004. Alterations in the dynamics of circulating ghrelin, adiponectin, and leptin in human obesity. Proc Natl Acad Sci USA. 101:10434–10439.
  • Yun JW. 2010. Possible anti-obesity therapeutics from nature – a review. Phytochemistry. 71:1625–1641.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.